logo
Plus   Neg
Share
Email

Genentech Says SUMMACTA Study Meets Primary Endpoint - Quick Facts

Genentech, a member of the Roche Group (RHHBY.PK), announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy (non-inferiority) of the subcutaneous formulation of ACTEMRA (tocilizumab) 162mg weekly compared to 8 mg/kg ACTEMRA intravenous formulation every four weeks.

A similar proportion of rheumatoid arthritis patients in each group achieved an ACR20 response at Week 24, a measure indicating improvement in the number of tender and swollen joints, pain scale, patients' and physicians' assessment of improvement and certain laboratory markers.

Hal Barron, chief medical officer and head, Global Product Development, stated, "We are very pleased with these data showing that subcutaneous administration of ACTEMRA provides clinically meaningful and comparable results to the IV infusion. This may provide patients and their doctors with an important additional treatment option."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Facing criticism from the government's top ethics watchdog, Commerce Secretary Wilbur Ross revealed Thursday he will sell all of his remaining stock holdings. A well-known investor prior to joining President Donald Trump's administration, Ross acknowledged making inadvertent errors in completing the divestitures required by his ethics agreement. Worldwide personal-computer shipments grew for the first time in six years during the second quarter of 2018, according to preliminary data from two market research firms. Gartner Inc. said that worldwide PC shipments increased 1.4 percent year-over-year to 62.1 million units in the second quarter of 2018, marking the first quarter of growth since the first quarter of 2012. The Centers for Disease Control and Prevention or CDC has recommended people to not eat any Kellogg Co.'s Honey Smacks cereal as it has been linked to a multistate outbreak of salmonella infections. According to the CDC, 100 people in 33 states have been infected with the outbreak strain. While 30 people have been hospitalized, no deaths have been reported.
Follow RTT